Christa Irene Nagel MD
Gynecologic Oncology
Associate Professor, The Ohio State University and James Comprehensive Cancer Center, Department of Obstetrics and Gynecology, Division of Gynecologic Oncology
Join to View Full Profile
460 W Tenth AveColumbus, OH 43210
Phone+1 614-293-7642
Fax+1 614-366-7942
Dr. Nagel is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Ohio State University/Mt Carmel HospitalResidency, Obstetrics and Gynecology, 2005 - 2009- Ohio State University College of MedicineClass of 2005
University of Texas Southwestern Medical CenterFellowship, Gynecologic Oncology
Certifications & Licensure
OH State Medical License 2005 - 2028
TX State Medical License 2010 - 2021
American Board of Obstetrics and Gynecology Obstetrics & Gynecology- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Sunrise Ambulatory Care, Allscripts, 2015-2016
- CMS Meaningful Use Stage 1 Certification Rhapsody Integration Engine, Orion Health, 2015-2016
- CMS Meaningful Use Stage 1 Certification Allscripts FollowMyHealth, Allscripts, 2015-2016
Clinical Trials
- Fenretinide/LXS Oral Powder Plus Ketoconazole in Recurrent Ovarian Cancer Start of enrollment: 2012 Feb 01
Publications & Presentations
PubMed
- Response to mirvetuximab soravtansine and weekly paclitaxel based on treatment sequencing in platinum-resistant ovarian cancer: Does order matter?Paulina J Haight, Julia C Sakach, Laura M Chambers, Floor J Backes, David E Cohn
Gynecologic Oncology. 2026-07-10 - PRO-PLATINUM: A randomized, double-blind, placebo controlled study to investigate the efficacy of a probiotic intervention on the gut and vaginal microbiome of ovarian...Laura M Chambers, Daniel Spakowicz, Julia Chalif, Reed O'Connor, Quinn Kistenfeger
Gynecologic Oncology. 2026-06-27 - Beyond extrapolation: Immunotherapy outcomes in recurrent vulvovaginal carcinoma.Cassidy S Abdeen, Reed M O'Connor, Julia Chalif, Danielle C Glassman, Anna Gonzalez
Gynecologic Oncology. 2026-05-27
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
